Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2006-08-15
2006-08-15
Badio, Barbara P. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C552S510000
Reexamination Certificate
active
07091195
ABSTRACT:
A composition and method of preventing or inhibiting tumor growth and, more particularly, of treating a malignant tumor, using prodrugs of plant-derived compounds and derivatives is disclosed. In the method, a composition containing betulinic acid or a betulinic acid derivative is administered in a prodrug form to release betulinic acid or a betulinic acid derivative in vivo at the tumor site.
REFERENCES:
patent: 5658947 (1997-08-01), DasGupta et al.
patent: 5804575 (1998-09-01), Pezzuto et al.
patent: 5869535 (1999-02-01), Pezzuto et al.
patent: 5962527 (1999-10-01), Pezzuto et al.
patent: 6048847 (2000-04-01), Ramadoss et al.
patent: 6225353 (2001-05-01), Pezzuto et al.
patent: 2003/0153538 (2003-08-01), Kuno et al.
patent: 0 943 620 (1999-09-01), None
patent: WO 93/10142 (1993-05-01), None
patent: WO 94/26725 (1994-11-01), None
patent: WO 00/46235 (2000-08-01), None
patent: WO 00/59492 (2000-10-01), None
patent: WO 02/09719 (2002-02-01), None
Ma et al., Phytotherapy Research, vol. 12, S138-S142, 1998.
Fujioka et al.,Journal of Natural Products, vol. 57, No. 2, pp. 243-247, Feb. 1994.
Sun et al.,J. Med. Chem., 41, pp. 4648-4657 (1998).
Yasukawa et al.,Phytomedicine, vol. 4, pp. 309-313 (1995).
Macias et al.,J. Chem. Col., 23(7), pp. 1781-1803 (1997), abstract only.
Pradhan et al.,Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem, 34B(6), pp. 540-542 (1995), abstract only.
Dina et al.,Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem, 34B(7), pp. 624-628 (1995), abstract only.
Patra et al.,Indian J. Chem., Sect. B, 27B(2), pp. 170-172 (1988), abstract only.
Tanaka et al.,J. Nat. Prod., 63(1), pp. 99-103 (2000), abstract only.
Kuo et al.,Chin. Pharm. J., 49(4), pp. 207-216 (1997), abstract only.
Evers et al.,J. Med. Chem., 39, pp. 1056-1068 (1996).
Mayaux et al.,Proc. Natl. Acad. Sci., USA, vol. 91, 3564-3568, Apr. 1994.
Fang et al.,Phytochemistry, 23(3), pp. 631-633 (1984), abstract only.
Macias et al.,Phytochemistry, vol. 49, No. 3, pp. 709-717 (1998).
Hashimoto et al.,Bioorganic&Medicinal Chemistry, vol. 5, No. 12, pp. 2133-2143 (1997).
Ma et al.,Chem. Pharm. Bull. 47(2), pp. 141-145 (1999).
Kim et al.,Bioorganic&Medicinal Chemistry Letters, 8(13), pp. 1707-1712 (1998).
Noda et al.,Chem. Pharm. Bull., 45(10), pp. 1665-1670 (1997).
Kitajima et al.,Chem. Pharm. Bull., 38(3), pp. 714-716 (1990).
Kashiwada et al.,J. Med. Chem., 39, pp. 1016-1017 (1996).
Goldsmith Miriam Elaine
Kosmeder, II Jerome W.
Pezzuto John M.
Xu Ze-Qi
Zhou Nian E.
Badio Barbara P.
Marshall & Gerstein & Borun LLP
The Board of Trustees of the University of Illinois
LandOfFree
Method of preparing and use of prodrugs of betulinic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of preparing and use of prodrugs of betulinic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preparing and use of prodrugs of betulinic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3674430